South San Francisco
About Calico Labs
Calico is a research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place.
September 18, 2013
Founder: Larry Page, Sergey Brin
CEO: Arthur Levinson
CSO (Scientific): David Botstein
26 articles about Calico Labs
Terray Therapeutics and Calico Life Sciences struck a research and development collaboration focused on the development of small-molecule therapeutics for age-related diseases.
Several biotech companies backed by billions are working on different approaches to developing the next big anti-aging therapy - from blood experiments to cell reprogramming.
In what seems like an unlikely collaboration, Seattle-based Fred Hutchinson Cancer Center (Fred Hutch) is partnering with Amazon to develop cancer vaccines.
The Baltimore Longitudinal Study of Aging was launched in 1958 by the National Institutes of Health. The idea was to follow and study the lives of healthy, active people over their lifetimes, rather than after they were dead.
After Unity Biotechnology chief executive officer Keith Leonard was on CNBC’s “Power Lunch,” touting the company’s therapeutic approach to longevity and aging, company shares soared almost 18 percent.
In another example of companies focused on aging-related diseases, Elevian launched with $5.5 million in seed funding. Elevian’s founders came out of Stanford and then Harvard, focused on regenerative effects of “young blood.”
Nearly four years after first forging a research collaboration, AbbVie and Calico, Google’s life science company, have extended that 10-year pact with another $1 billion pledge to develop therapies associated with age-related diseases, including neurodegeneration and cancer.
AbbVie and Calico Announce Extension of Groundbreaking Collaboration
Extension builds on collaboration established in 2014
Venture capital firm Foresite Capital, located in San Francisco, is launching a new fund, its fourth and largest, worth $668 million.
Google's Mysterious Biotech Calico Forms a Rare Deal With C4 Therapeutics
Calico Responds to Job Cut Rumors
Google's Calico Hires Another Big Name in Quest to Unlock Healthy Aging
Nine Bay Area Biotechs Vie to be the “Next Genentech”
Technology Will Human Beings Live Forever? These Companies Are Betting On It
Alphabet Wants Its Startups Like Biotech Calico To Start Behaving Like Startups
Google's Calico Forage Ancestry.com to Find Out What's in Your Genes
Calico Inks Deal With Buck Institute, Will Hire A Dozen and Set Up Shop in Novato
Google's Mystery Biotech Calico Cuts Local Longevity R&D Pact
Google Inc.'s Calico Snags SSF Space As it Ramps Up Hiring
Google Inc.-Backed Calico Announces Plan To Combat ALS, Parkinson's